Combined hormonal contraceptive

A combined hormonal contraceptive (CHC) is any contraceptive that delivers both a synthetic estrogen (usually ethinyl estradiol) and a synthetic progestin. The three common forms are the combined oral pill, the contraceptive patch, and the vaginal ring. All three use the same hormonal mechanism, only the delivery route differs.

CHCs are among the most effective reversible contraceptives, with typical-use efficacy around 91% and perfect-use efficacy above 99%. They are also the form of birth control most relevant to cycle syncing, because they remove the natural cycle entirely.

This is informational, not medical advice. Contraceptive choice should be discussed with a qualified provider.

How it works

CHCs suppress the HPO axis. The steady delivery of synthetic estrogen and progestin keeps FSH and LH low, which prevents follicle maturation and blocks the LH surge. Without an LH surge, ovulation does not happen.

Three contraceptive effects stack:

  1. Ovulation is suppressed (the primary mechanism).
  2. Cervical mucus thickens, reducing sperm penetration.
  3. The endometrium becomes thin and less receptive to implantation.

The bleed that occurs during the placebo week (or ring-free week) is not menstruation. It is withdrawal bleeding triggered by the abrupt removal of synthetic hormones. There is no true follicular or luteal phase on a CHC.

Cycle implications

Because ovulation is suppressed, the four-phase cycle that cycle syncing describes does not exist. You do not have a follicular surge of estrogen, an LH peak, a corpus luteum, or a natural progesterone rise. Instead you have steady-state synthetic hormone levels for three weeks, then a withdrawal week.

Practical implications:

  • Phase-based scheduling that depends on hormonal events does not apply.
  • Symptom patterns (energy, mood, libido, sleep) tend to be flatter overall, with some users reporting reduced premenstrual symptoms and others reporting flatter affect or reduced libido.
  • The 28-day calendar rotation can still be used as a structural template (Reflect, Build, Connect, Finish), but the biological rationale is gone.

The cycle syncing on birth control guide walks through each method in detail.

Common side effects

CHCs are generally well tolerated but have a well-documented side effect profile:

  • Breakthrough bleeding in the first three cycles.
  • Breast tenderness, often estrogen-driven.
  • Nausea, especially in the first month.
  • Mood changes. A subset of users report low mood, anxiety, or flattened affect. Evidence is mixed at population level but consistent in clinical practice.
  • Reduced libido. Synthetic estrogen raises SHBG, which lowers free testosterone.
  • Headaches, including new or worsened migraines.
  • Slight increase in blood clot risk, particularly in users who smoke, are over 35, have migraine with aura, or have a clotting disorder.

When to consider

CHCs are a reasonable choice for users who want highly effective reversible contraception, predictable scheduled bleeds, and symptom-flattening effects on conditions like PMS, heavy bleeding, endometriosis pain, or PCOS-related acne and irregular cycles.

When NOT to consider

CHCs are usually avoided in users with:

  • Migraine with aura (raised stroke risk).
  • History of blood clots, stroke, or heart attack.
  • Smokers over 35.
  • Uncontrolled high blood pressure.
  • Active estrogen-sensitive cancer.
  • Liver disease.

Progestin-only methods like the mini-pill or the hormonal IUD are often offered when estrogen is contraindicated.

Related reading